- Home
- TNDM
as of 12-05-2025 3:46pm EST
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.
| Founded: | 2006 | Country: | United States |
| Employees: | N/A | City: | San Diego |
| Market Cap: | 1.1B | IPO Year: | 2013 |
| Target Price: | $22.00 | AVG Volume (30 days): | 2.7M |
| Analyst Decision: | Buy | Number of Analysts: | 16 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.05 | EPS Growth: | N/A |
| 52 Week Low/High: | $9.98 - $38.28 | Next Earning Date: | 11-06-2025 |
| Revenue: | $1,007,001,000 | Revenue Growth: | 17.87% |
| Revenue Growth (this year): | 8.59% | Revenue Growth (next year): | 10.19% |
AI-Powered TNDM Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Compare TNDM vs Leading Stocks
See how TNDM stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "TNDM Tandem Diabetes Care Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.